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Objective: Hypertrophy-like changes are often observed in chondrocytes during the development of
osteoarthritis (OA). These changes play a crucial part in the OA-associated cartilage degradation and
osteophyte formation. However, the pathogenesis leading to such changes is still unknown. In this study,
we investigated the mechanism by which these hypertrophy-like changes are induced from the view-
point of impaired glycolytic metabolism.
Methods: The effect of sodium ﬂuoride (NaF) on glycolytic metabolism of cultured chondrocytes was
conﬁrmed by measurement of intracellular adenosine triphosphate (ATP) production. Translocation of
phosphorylated Smad1/5/8 to the nucleus was evaluated by subcellular fractionation and Western
blotting. Chondrocyte hypertrophy-like changes were investigated by real-time RT-PCR and Western blot
analysis of differentiation markers.
Results: ATP production was dose-dependently decreased by NaF in the human chondrocytic cell line
HCS-2/8. In addition, both chondrocyte proliferation and differentiation were inhibited, whereas cell
death was promoted by treatment with NaF. Interestingly, combinational treatment with NaF and lactate
enhanced translocation of phospho-Smad1/5/8 to the nucleus, as well as gene expression of ALP, VEGF,
COL10a1, and matrix metalloproteinase13 (MMP13), which were the markers of late mature and hy-
pertrophic chondrocytes. Furthermore, the production of type X collagen and activation of MMP9 were
also promoted under the same conditions.
Conclusions: These ﬁndings suggest that decreased ATP production by NaF promotes hypertrophy-like
changes via activation of phospho-Smad1/5/8 in the presence of lactate. Novel metabolic aspects of
OA pathogenesis are indicated herein.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is one of the most prevalent joint diseases
and is characterized by an age-dependent, slowly progressive
degeneration of articular cartilage1. In OA, distinct stages can be
recognized during disease progression in terms of the degenerationoride; MMPs, matrix metal-
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s Research Society International. Pof cartilage1. At the initiation stage, the behavior of the chon-
drocytes becomes altered due to aging or excess mechanical stress,
and the cells acquire a hypertrophy-like phenotype, producing type
X collagen and matrix metalloproteinase13 (MMP13)1,2. Next,
during the progression stage, the release and activation of MMP13
lead to degradation of the extracellular matrix (ECM) surrounding
the chondrocytes; and the fragmented ECM molecules, forming an
altered biomechanical environment, inﬂuence these chondrocytes
such that the hypertrophy-like changes become accelerated1,2.
Thereafter, at the late and end stages, chondrocyte clusters, which
are formed in an unsuccessful attempt to repair the cartilage tissue,
appear in severely damaged cartilage and peri-articular formation
of new bone (osteophytosis) occurs1,2. Eventually, the cartilage
tissue degenerates, thus exposing the underlying bone1,2. Under
such conditions, this disease clinically leads to loss of joint func-
tion3. The incidence of OA is thought to be associated with many
risk factors, such as metabolic disease, aging, obesity, and me-
chanical stress1,2. However, the pathogenic mechanism, inublished by Elsevier Ltd. All rights reserved.
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hypertrophy-like changes at the initiation stage in OA, is still
unclear.
To estimate possible factors involved in the hypertrophy-like
changes, we focused on two experimental models4. One of the
models is an arthritis model induced by the intra-articular injection
of monoiodoacetate (MIA), which inhibits the activity of glyceral-
dehyde 3-phosphate dehydrogenase (GAPDH), one of the glycolysis
enzymes5. In this model, widespread chondrocytes are depleted
throughout the cartilage tissue, cartilage ECM is also lost in the
central part of the articular cartilage, and, furthermore, chon-
drocytes form clusters at the surface of articular cartilage4. The
other one is the K/BxN mouse model, in which a spontaneously
erosive arthritis is manifested6,7. The phenotype is characterized by
many features common to rheumatoid arthritis (RA), including
leukocyte invasion, synoviocyte proliferation, and erosion of carti-
lage and bone6,7. Recently, it was reported that the arthritis in the
K/BxN mouse is caused by autoantibody against glucose-6-
phosphate isomerase (GPI), which is another of the glycolysis en-
zymes7. Since these two animal models commonly exhibit severe
cartilage destruction, this cartilage destruction may be caused by
inhibition of the glycolysis enzymes. Therefore, we hypothesized
that a part of cartilage destruction might be triggered by dysregu-
lation of glucose metabolism in chondrocytes. Indeed, it is well
known that cartilage is an avascular tissue and that chondrocytes
generate energy in the form of adenosine triphosphate (ATP),
mostly dependent on anaerobic metabolism of glucose8. Therefore,
if this metabolism is impaired, intracellular ATP production is
profoundly decreased; and the chondrocytes are forced to degen-
erate, following the pathway to hypertrophy-like changes.
Bone morphogenetic protein (BMP) signaling has been already
known to be required for onset of chondrocyte hypertrophy9. Since
Smad1/5/8 signaling, is a canonical pathway of BMP signaling,
involvement of this signaling pathway in the hypertrophy-like
changes due to impaired glycolysis is suspected. To examine this
hypothesis, we used an in vitro culture system employing primary
rat chondrocytes isolated from epiphyseal cartilage10 and two
useful immortalized chondrocytic cells lines, human chondrocytic
HCS-2/8 cells11e13 and rat chondrocytic RCS cells14. In the present
study, we clariﬁed that intracellular ATP production decreased
by a few speciﬁc inhibitors of glycolysis caused chondrocyte
hypertrophy-like changes via activation of Smad1/5/8 by lactate,
which is an end product of glycolysis.
Materials and methods
Materials
Dulbecco’s modiﬁed Eagle’s medium (DMEM), a-modiﬁcation of
Eagle’s medium (aMEM), and fetal bovine serum (FBS) were pur-
chased from Nissui Pharmaceutical Co. Ltd. (Tokyo, Japan), ICN
Biomedicals (Aurora, OH), and Nichirei Bioscience Inc. (Tokyo,
Japan), respectively. Plastic dishes and multi-well plates were ob-
tained from Greiner Bio-One (Frickenhausen, Germany). Sodium
ﬂuoride (NaF) was purchased fromWako Pure Chemical Industries
(Osaka, Japan). Sodium lactate, iodoacetate sodium salt, anti-b-
actin, anti-proliferating cell nuclear antigen (PCNA), and anti-type
X collagen antibodies were obtained from Sigma (St. Louis, MO).
Anti-monocarboxylate transporter (MCT)2, anti-MMP13, and anti-
SOX9 antibodies were from Millipore (Temecula, CA). Anti-MMP9
was purchased from Triple Point Biologics, Inc. (Forest Grove,
OR); and anti-nuclear factor (NF)-kB p65 and anti-MCT1, from
Santa Cruz Biotechnology (Santa Cruz, CA). Anti-phospho-Smad1/
5/8 from Cell Signaling Technology (Beverly, MA) and anti-lamin
B1 from Life Technologies (Grand Island, NY) were also employed.Cell culture
HCS-2/811e13 cells were inoculated at a density of 4  104 cells/
cm2 into culture dishes containing DMEM supplemented with 10%
FBS and incubated at 37C under 5% CO2. RCS cells14 were cultured
in monolayer, pellet and collagen gel. For monolayer, RCS cells were
seeded at a density of 2.5  104 cells/cm2 in DMEM containing 10%
FBS and incubated at 37C under 5% CO2. For pellet culture, 5  106
cells per pellet were centrifuged and then cultured at 37C under
5% CO2. For collagen gel 3-dimensional (3-D) culture, the cells were
embedded at a density of 2  105 cells/dish into collagen scaffold
(Cellmatrix; Nitta Gelatin Inc. Osaka, Japan) and cultured under
normoxia or hypoxia (5% O2) by using multigas incubator (BIO-
LABO, Tokyo, Japan) at 37C. Rat chondrocytes were isolated from
the epiphyseal cartilage of 5-day-old Wistar rats as described pre-
viously10. The isolated chondrocytes were seeded at a density of
1  104 cells/cm2 and cultured at 37C under 5% CO2 in aMEM
containing 10% FBS. The Animal Committee of Okayama University
Graduate School of Medicine, Dentistry, and Pharmaceutical Sci-
ences approved all of the procedures.
Cell proliferation assay
HCS-2/8 cells were inoculated into a 96-well multi-plate at a
density of 3  104 cells/well; and the next day the medium was
replaced with serum-free medium containing NaF at various con-
centrations (1, 5 and 10 mM). Then the cells were cultured for 16 h.
The effect of NaF on cell proliferation was determined by per-
forming a cell proliferation enzyme-linked immunosorbent assay
(ELISA), 5-bromo-20-deoxyuridine (BrdU) colorimetric (Roche
Applied Science, Mannheim, Germany) according to the manufac-
turer’s protocol15.
Detection of intracellular ATP
For measurement of intracellular ATP, an ATP bioluminescence
assay kitwas obtained and used according tomanufacturer’s (Roche
Applied Science) recommendations. Brieﬂy, after HCS-2/8 cells had
been treated with NaF in the absence or presence of sodium lactate
for 16 h, they were harvested. The cells were then boiled for 2 min
for the preparation of cell lysates, and 50 ml of samples/standards
was transferred to a white plate. Then, the luciferase reagent was
added, and the emitted light was measured with a luminometer
(Fluoroskan Ascent FL; Thermo Labsystems, Franklin, MA).
Detection of cytotoxicity
For detection and quantiﬁcation of cell death by NaF, we per-
formed terminal deoxynucleotidyl transferase dUTP nick end la-
beling (TUNEL) staining of rat chondrocytes and measurement of
the lactate dehydrogenase (LDH) activity in conditioned media of
HCS-2/8 cells by using an in situ cell death detection kit and cyto-
toxicity detection kit (Roche Applied Science), respectively.
Luciferase assay
The ﬁreﬂy luciferase reporter construct containing the Smad
binding element (SBE) and hypoxia response element (HRE)
at -1006/-954 of VEGF promoter16 and herpes simplex virus
thymidine kinase promoter-Renilla luciferase reporter plasmid
(pRL-TK, internal control: Promega, Madison, WI) were used. HCS-
2/8 cells were transfected with 0.9 mg of reporter plasmid in com-
binationwith 0.1 mg of pRL-TK using Fugene6 reagent (Roche, Basel,
Switzerland). The dual luciferase system (Promega) was used as
described previously16.
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HCS-2/8 or RCS cells were treated with NaF, sodium lactate or a
combination of lactate and NaF. After 18 h, the cell lysates were
prepared, and the nuclear and cytoplasmic proteins were separated
by using a CelLytic NuCLEAR extraction kit (Sigma) according to the
manufacturer’s protocol. Western blot analysis was performed as
described previously17.
Quantiﬁcation of sulfated glycosaminoglycan (GAG) contents
Rat epiphyseal chondrocytes were grown to conﬂuence in 96-
well multi-plates containing aMEM supplemented with 10% FBS.
Thereafter, the cells were treated with NaF at several concentra-
tions for 4 days. A microassay for sulfated GAG’s was performed as
described previously18.
Real-time reverse transcription-polymerase chain reaction (RT-PCR)
analysis
Total RNA was isolated from HCS-2/8 cells by using ISOGEN re-
agent (Nippon Gene, Tokyo, Japan). First-strand cDNA was syn-
thesized with a Takara RNA PCR kit (AMV) Version 3.0 (Takara
Shuzo, Tokyo, Japan), and ampliﬁcation reactions were performed
with a SYBR Green Real-time PCR Master Mix (Toyobo, Tokyo,
Japan)16. The nucleotide sequences of the primers and expected
size of the amplicons are shown in Table I.
Indirect immunoﬂuorescence analysis
RCS cells were cultured on chamber slides (Nunc Inc., Naperville,
IL) for 2 days. Then, the cells were treated with NaF combined with
lactate. After 22 h, the cultures were washed with phosphate-
buffered saline (PBS), ﬁxed with 3.5% paraformaldehyde for 1 h at
room temperature, and made permeable with 0.1% NP-40 in PBS.
Indirect immunoﬂuorescence analysis was then performed as
described previously19.
Statistical analysis
Statistical analyses were performed by using a software (Stat-
View, version 5.0, SAS Institute Inc., Cary, NC). To assess normality
for the observed differences, KolmogoroveSmirnov test was used
and showed no strong departure from normality. Therefore, the
statistical analysis was performed using the two-tailed unpaired
Student t test. Results are presented as mean values with 95%Table I
Sense (S) and antisense (AS) primers used for PCR
Gene Accession no. Primer
COL10a1 NM_000493.3 (F) 50-G
(R) 50-T
MMP13 NM_002427.3 (F) 50-T
(R) 50-A
ALP NM_001127501.2 (F) 50-G
(R) 50-C
VEGF NM_001171630.1 (F) 50-C
(R) 50-A
ACAN NM_013227.3 (F) 50-G
(R) 50-C
b-actin NM_001101.3 (F) 50-G
(R) 50-A
MCT1 NM_003051.3 (F) 50-C
(R) 50-C
MCT2 NM_004731.3 (F) 50-C
(R) 50-Cconﬁdence intervals. In the dot plots, exact P-values are presented
for all data sets with signiﬁcant differences.
Results
Sugar metabolism impaired by NaF inhibits the proliferation and
differentiation and promotes cell death of chondrocytes
Because NaF and iodoacetate are respective inhibitors of enolase
and GAPDH, which are critical enzymes of glycolytic pathways, these
factors speciﬁcally block glycolytic metabolism. We ﬁrstly examined
whether ATP production in chondrocytic HCS-2/8 cells would be
affected or not by NaF or iodoacetate. As shown in Fig.1(A and B), the
content of intracellular ATP in the cellswas signiﬁcantly decreased by
NaFand iodoacetate at all doses tested. These results indicate that the
decreased intracellular ATP production was due to NaF or iodoace-
tate, thus suggesting that glycolysis was the principal pathway to
supply ATP in the chondrocytes. Next, to investigate the effect of
decreased ATP content on chondrocyte proliferation and differenti-
ation, we performed a cell proliferation assay and Western blot
analysis of lysates of NaF-treated HCS-2/8 cells by using anti-PCNA
antibody. As shown in Fig. 2(A) (upper panel), the signal of PCNA,
which is a marker of cell proliferation, was decreased by the treat-
ment with NaF. Similarly, treatment with 5 or 10 mM NaF signiﬁ-
cantly decreased the incorporation of BrdU into the cells [Fig. 2(A),
lower panel]. Subsequently, in order to test the effect of NaF on the
differentiation of chondrocytes, we comparatively analyzed sulfated
proteoglycan, which is a typical marker of differentiated chon-
drocytes, accumulated by rat chondrocytes treated with various
concentrations of NaF. As a result, the accumulation of sulfated GAG
was signiﬁcantly inhibited by NaF in a dose-dependent manner
[Fig. 2(B)]. Theseﬁndings suggest that both chondrocyte proliferation
and differentiation were impaired by decreased intracellular ATP
production caused by addition of NaF. Finally, we tested whether
treatmentwithNaF-induced cell death, or not, by TUNEL staining and
the measurement of LDH activity released from damaged cells into
cultured medium. As shown in Fig. 2(C and D), although 1 mM NaF
had no effect, 5 mM NaF remarkably increased TUNEL positive cells
and LDH activity in the supernatant. Taken together, these ﬁndings
show that NaF-elicited blockade of ATP production, a major energy
source for chondrocytes, inhibited both cell proliferation and differ-
entiation, while promoting cell death.
No rescue effect of lactate on the ATP production impaired by NaF
We suspected that the impaired chondrocyte proliferation and
differentiation by treatment with NaF were due to the reduced ATPsequence Expected size (bp)
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Fig. 1. Metabolic activity of HCS-2/8 cells treated with NaF or iodoacetate as measured by ATP bioluminescence assay. (A) HCS-2/8 cells were cultured until they had reached
conﬂuence. Then, they were treated with NaF (1, 5, or 10 mM). Sixteen hours later, cell lysates were prepared and the ATP level was measured with an ATP bioluminescence assay
kit. The ordinate shows relative light units (rlu) of luminescence. Each dot represents the value determined for each of the individual samples (n ¼ 6), and bars represent means and
95% conﬁdence intervals. Exact P-values are indicated between compared groups. (B) HCS-2/8 cells were treated with iodoacetate at 5, 10, or 20 mM for 16 h. The ordinate shows rlu
of luminescence. Data show the value of three independent samples, and bars represent means and the 95% conﬁdence intervals. Exact P-values are indicated on the graphs.
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rescued by the addition of lactate, which is the end product of the
glycolytic pathway, it would indicate that aerobic metabolism after
glycolysis could be a major source of ATP. To address this issue, we
measured the intracellular ATP content in HCS-2/8 cells treated
with NaF or iodoacetate in the presence of sodium lactate. How-
ever, there was no recovery of the decreased intracellular ATP
production when lactate was present [Fig. 3(A and B)]. Then, we
speculated that because MCTs, which mediate lactate transport,
might not be expressed in HCS-2/8 cells, intracellular ATP pro-
duction might not be supported by the addition of lactate. To
examine this possibility, we analyzed the gene expression of MCT1
and 2 by performing real-time RT-PCR analysis. As a result, the
expression of MCT1 was detected in the untreated HCS-2/8 cells
and was decreased in the cells treated with NaF or the NaF com-
bined with lactate [Fig. 4(Aa)]. On the other hand, the gene
expression of MCT2 was remarkably increased in HCS-2/8 cells
treated with NaF or the NaF combined with lactate in the com-
parison with that in the untreated ones [Fig. 4(Ab)]. In addition,
Western blot analysis revealed that MCT1 protein was decreased in
pellet culture of RCS cells treated with NaF, but MCT2 protein was
increased [Fig. 4(B)]. Furthermore, immunoﬂuorescence analysis
revealed that immunoreactivity for MCT2 was detected in the
cytoplasm and on the cell-surface [Fig. 4(C)]. These ﬁndings indi-
cate that MCT2 was increased at both mRNA and protein levels by
treatment with NaF or NaF combined with lactate, thus suggesting
that lactate could have been transported into the NaF-treated
chondrocytes via MCT2.
Sodium lactate enhances the BMP signaling but not NF-kB signaling
under the condition of lowered ATP production in HCS-2/8 cells
Recently, it was reported that MCT1 contributes to cell death
through activation of NF-kB in mouse chondrocytic ATDC5 cells20.
Therefore, to test whether MCT2 induced by NaF could also mediate
cell death through the activation of NF-kB, we comparatively
analyzed the translocation of NF-kB into the nucleus of HCS-2/8 cells
treated with NaF in the presence of lactate. As shown in Fig. 5(A),
when lactate was added to HCS-2/8 cells treated with NaF, the
translocation of NF-kB into the nucleus showed no change. However,
interestingly, more phospho-Smad1/5/8 was translocated to the
nucleus of the cells treated with NaF in the presence of lactate thanthat in its absence [Fig. 5(A)]. As phospho-Smad1/5/8 is involved in
BMP signaling9, these ﬁndings suggest that lactate enhanced BMP
signaling in HCS-2/8 cells in collaboration with NaF that induces
MCT2. To assess this ﬁnding, HCS-2/8 cells were transfected with the
luciferase reporter plasmid containing HRE and SBE located within
VEGF promoter, and reporter gene assaywas performed. As shown in
Fig. 5(B), luciferase activity was more increased in HCS-2/8 cells
treatedwith NaF in the presence of lactate than in its absence. On the
other hand, luciferase activity in the untreated cells did not change
with lactate [Fig. 5(B)]. Taken together, these ﬁndings suggest that
BMP signaling was enhanced by lactate in collaboration with NaF-
induced MCT2 that mediated lactate uptake.
Combination of NaF and lactate induces chondrocyte hypertrophy-
like changes
Because it has been already reported that BMP signaling pro-
motes chondrocyte hypertrophy9, we next investigated whether
the chondrocyte hypertrophy-like changes were provoked by
treatment with the combination of NaF and lactate. As shown in
Fig. 6(A), the gene expression of COL10a1 (a), ALP (b), MMP13 (c),
and VEGF (d), all of which are markers of hypertrophic chon-
drocytes, was promoted by treatment with NaF or it in combination
with lactate more strongly than by that with PBS or lactate alone. In
particular, the gene expressions of COL10a1 and ALP were stimu-
lated to a greater extent by the combination with lactate than by
NaF alone. In addition, the gene expression of AGGRECAN (ACAN, e),
which is a marker of mature chondrocytes, was decreased in the
cells treated with NaF or NaF combined with lactate comparedwith
its expression in the presence of PBS or lactate alone. It has been
generally believed that 3-D culture of chondrocytes under hypoxic
condition is suitable for mimicking the cartilage environment.
Therefore, RCS cells were embedded into collagen scaffold and
were treated with NaF combined with lactate under hypoxia for
24 h. As shown in Fig. 6(B), the gene expression level of COL10a1
was increased under hypoxia compared with its expression under
normoxia. Furthermore, COL10a1 expression was signiﬁcantly
increased by treatment with NaF combined with lactate under both
normoxia and hypoxia. These results suggest that NaF combined
with lactate promoted chondrocyte hypertrophy-like changes in
both monolayer and 3-D collagen cultures and under both nor-
moxia and hypoxia.
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Fig. 2. Effect of NaF on the proliferation, differentiation, and cell death of cultured chondrocytes. (A) Effect of NaF on the proliferation of HCS-2/8 cells. (Upper) HCS-2/8 cells were
cultured in 35-mm diameter dishes with DMEM containing 10% FBS. After the cells had reached conﬂuence, they were treated with NaF at 5 mM for 16 h. Then, cell lysates were
prepared and Western blot analysis was performed by using anti-PCNA and b-actin antibodies. (Lower) HCS-2/8 cells were inoculated into 96-well multi-plates, and the next day,
the mediumwas replaced with serum-free DMEM containing NaF at 1 (n ¼ 10), 5 (n ¼ 10) or 10 (n ¼ 8) mM. The negative control was added with PBS (n ¼ 10). After 16 h, BrdU was
added; and the cells were then incubated for an additional 3 h. Measurement of BrdU incorporation was determined as immunoreactivity with anti-BrdU antibody. Each dot shows
the value from an independent sample and bars represent mean values and the 95% conﬁdence intervals. Exact P-values between the indicated groups, are given on the graph. (B)
Effect of NaF on the differentiation of rat chondrocytes. Sulfated GAG microassay using rat epiphyseal chondrocytes was performed as described in Materials and methods. Each dot
shows the value from an independent culture (n ¼ 5) and bars represent means and the 95% conﬁdence intervals. Exact P-values are indicated. (C) Fluorescent TUNEL staining in rat
epiphyseal chondrocytes treated with NaF. Rat chondrocytes were cultured in a 24-well multi-plate until they had reached conﬂuence. Then the cells were treated with NaF at 1 or
5 mM. After 16 h, the cells were ﬁxed; and TUNEL staining was then performed. Bar represents 250 mm. (D) Measurement of LDH activity in the conditioned media of HCS-2/8 cells
treated with NaF. After the cells were treated with NaF at 1 (n ¼ 9) or 5 (n ¼ 9) mM for 16 h, cell death was determined by LDH release into the conditioned media. The negative
control was added with PBS (n ¼ 8). Dots show the values from independent cultures and bars represent means and the 95% conﬁdence intervals. Exact P-values are indicated.
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stimulated the production of type X collagen in HCS-2/8 cells, we
performed Western blot analysis. As shown in Fig. 7(A), the pro-
duction of type X collagen was increased by NaF combined with
lactate. On the other hand, as it is already known that SOX9 is
decreased in hypertrophic chondrocytes21, we also investigated
whether production of SOX9 was decreased by treatment with NaF
combined with lactate. As expected, SOX9 production was
decreased by NaF, or NaF combined with lactate [Fig. 7(A)].Additionally, to examine whether or not these results were due to
decreased ATP production, we performed similar experiments us-
ing iodoacetate. As a result, similar results were obtained (data not
shown). Furthermore, the active form of MMP9, which is another
marker of hypertrophic chondrocytes, was detected in medium
conditioned by HCS-2/8 cells treated with NaF or NaF combined
with lactate [Fig. 7(B)]. Taken together, these ﬁndings suggest that
ATP production deﬁciency by NaF and lactate accumulation
induced the chondrocyte hypertrophy-like changes.
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In this study, we clariﬁed that treatment with NaF impaired
chondrocyte proliferation and differentiation, and promoted cell0 
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Fig. 5. Promotion of phospho-Smad1/5/8 transport into the nucleus of HCS-2/8 cells
by the addition of lactate. (A) HCS-2/8 cells were cultured in 35-mm diameter dishes
with DMEM containing 10% FBS until they had become conﬂuent. Then, the medium
was replaced with serum-free DMEM containing 2 mM NaF. After 18 h, the cells were
incubated for 30 min with lactate at 1 mM; and the nuclear (N) and cytoplasmic (C)
proteins were then prepared. Successful fractionation was conﬁrmed by Western
blotting of the fraction markers of the nucleus (lamin B1) and cytoplasm (b-actin).
Western blotting was performed by using anti-p65 antibody (NF-kB) and anti-
phospho-Smad1/5/8 antibody. (B) HCS-2/8 cells were transiently transfected with
the ﬁreﬂy luciferase reporter plasmid containing SBE and HRE at -1006/-954 of VEGF
promoter together with pRL-TK plasmid (internal control). Next day, the cells were
treated with NaF (2 mM) and lactate (1 mM). After 16 h, the cells were treated with
1 mM lactate for 30 min, and the cell lysate was collected. Then, luciferase assay was
performed. The data show the means and the 95% conﬁdence intervals of relative
values of the measured luminescence of ﬁreﬂy vs Renilla luciferase from independent
cultures (n ¼ 5). Exact P-values are indicated where signiﬁcant differences were
observed.
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tionwas rescued by the addition of lactate that could be catabolized
through pyruvate for aerobic ATP production, it was not rescued
against our expectations. This outcome represents anaerobic
glycolysis as the major metabolic pathway to supply ATP in chon-
drocytes. More interestingly, during this degenerative process,
lactate stimulated translocation of phospho-Smad1/5/8 into the
nucleus (Fig. 5). As a result, the gene expression and protein pro-
duction level of COL10a1 were increased, and the production of
SOX9, which was decreased in hypertrophic chondrocytes, was
decreased (Figs. 6 and 7). These results suggest that decreased
ATP production by treatment with NaF promoted chondrocyte
hypertrophy-like changes in the presence of lactate.
NaF has been commonly used as an additive to drinking water
for the prevention of dental caries. Previously, it was reported that
the thickness of the temporomandibular joint cartilage layer in rats
is increased when the animals are given 0.1% NaF in their drinking
water, an increase attributable to a histologically demonstratedincrease in the thickness of the hypertrophic zone22. The referenced
authors suggested that enlargement of the hypertrophic zone was
due to the accumulation of glycogen by inhibition of glycolytic
pathways in chondrocytes and to the delayed capillary invasion
into cartilage ECM22. Based on the above discussion and the results
of our experiments, the hypertrophic zone enlarged by ﬂuoride
exposure may be attributable to an increase in the number of hy-
pertrophic cells promoted by decreased ATP production, inefﬁcient
removal of terminally differentiated hypertrophic chondrocytes
caused by delayed vascular invasion, and an increase in cell size
caused by glycogen accumulation in the chondrocytes.
Chondrocytes utilize predominantly glycolytic metabolism to
produce optimal ATP due to the surrounding avascular microen-
vironment, yielding lactate as the end product23,24. Lactate is
released into the surrounding matrix to maintain normal intracel-
lular pH via MCTs23,24. MCTs are a family of integral membrane
proteins that mediate proton-coupled co-transport of mono-
carboxylic acids across the cell membrane, and nine MCT-related
homologs have been identiﬁed in mammals thus far25. Among
them, direct transportation of lactate and pyruvate transport
have been demonstrated for mammalian MCT1eMCT425. In chon-
drocytes, mRNA expression of MCT1, 2, and 4 isoforms, but not the
MCT3 isoform, is detectable; and MCT2 expression is the lowest
among these isoforms26. In this study, we conﬁrmed that MCT2
expressionwas lower than MCT1 expression in HCS-2/8 cells under
normal culture conditions [Fig. 4(A)]. However, treatment with NaF
revealed that MCT2 expression was dramatically up-regulated
[Fig. 4(A)]. Furthermore, it was previously reported that MCT2
has a tenfold higher afﬁnity for cargo than MCT1 or MCT425. One
may expect that pyruvate converted from lactate transported into
chondrocytes via MCT2 may increase intracellular ATP via aerobic
catabolism. However, consistent with the fact that chondrocytes
predominantly use glycolysis to obtain ATP, lactate had no effect on
the production of ATP in HCS-2/8 cells treated with NaF or iodoa-
cetate (Fig. 3). Thus, we hypothesized that lactate might be an
activator of cell signaling pathways rather than a pyruvate pre-
cursor. A previous study indicates that lactate activates toll-like
receptor 4 (TLR4) signaling and NF-kB pathways in macrophages
through up-regulation of MCTs27. In addition, it was recently
revealed that stimulation by lactate leads to activation of signal
transducers and activators of transcription 3 (STAT3) and extra-
cellular signal-regulated kinase (ERK)1/2 signaling pathways in
human mesenchymal stem cells28. In view of these ﬁndings, we
investigated the effect of lactate on the transport of NF-kB into the
nucleus in HCS-2/8 cells treated with NaF but found no promotion
of NF-kB transport [Fig. 5(A)]. However, surprisingly, the transport
of phospho-Smad1/5/8 into the nucleus was increased by lactate
stimulation [Fig. 5(A)]. It is well known that activation of BMP
signaling promotes proliferation and differentiation of chon-
drocytes and furthermore promotes chondrocyte hypertrophy9.
Our earlier immunohistochemical analysis revealed that BMP-2 is
localized in the perichondrium and pre-hypertrophic zone in the
growth plate29. Furthermore, phosphorylated forms of Smad1/5/8
are immunohistochemically detectable in the pre-hypertrophic
zone of the growth plate but not in the perichondrium30. These
ﬁndings suggest that BMP signaling pathways, engaged by
phospho-Smad1/5/8, would be activated in the pre-hypertrophic
zone. Taken together, our and the referenced data indicate that
both initiation of BMP signaling via BMP-2 and promotion of
phospho-Smad1/5/8 transport into the nucleus by lactate would
work cooperatively. As a result of this cooperation between a
metabolite and growth factor, pre-hypertrophic chondrocytes may
differentiate into hypertrophic chondrocytes efﬁciently.
Articular cartilage is an avascular connective tissue and has an
important role in resistance against mechanical stimulation of
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Fig. 6. Real-time RT-PCR analysis of chondrocyte marker gene expression in cultured chondrocytes treated with NaF and/or lactate. (A) HCS-2/8 cells were grown in DMEM
containing 10% FBS until they had become conﬂuent. Then, the cells were treated with NaF (2 mM), lactate (1 mM) or NaF combined with lactate; and total RNA was prepared 16 h
later. Real-time RT-PCR analysis was performed by using COL10a1-, ALP-,MMP13-, VEGF-, ACAN- and b-actin-speciﬁc primers. The amount of expression of each chondrocyte marker
genes was normalized to the amount of b-actin. (a) Graph shows the expression level of COL10a1 in HCS-2/8 cells treated with PBS (n ¼ 6), NaF (n ¼ 6), lactate (n ¼ 6), or NaF
combined with lactate (n ¼ 5). (b) Graph shows the expression level of ALP in HCS-2/8 cells treated with PBS (n ¼ 9), NaF (n ¼ 8), lactate (n ¼ 9), or NaF combined with lactate
(n ¼ 7). (c) Graph shows the expression level ofMMP13 in HCS-2/8 cells treated with PBS (n ¼ 6), NaF (n ¼ 5), lactate (n ¼ 6), or NaF combined with lactate (n ¼ 5). (d) Graph shows
the expression level of VEGF in HCS-2/8 cells treated with PBS (n¼ 9), NaF (n ¼ 7), lactate (n ¼ 9), or NaF combined with lactate (n ¼ 8). (e) Graph shows the expression level of ACAN
in HCS-2/8 cells treated with PBS (n ¼ 6), NaF (n ¼ 6), lactate (n ¼ 6), or NaF combined with lactate (n ¼ 6). In all the graph, the ordinate indicates the relative ratio with respect to
control sample (ratio ¼ 1.0), and bars represent means and the 95% conﬁdence intervals. Exact P-values are shown between two data sets with signiﬁcant differences. (B) RCS cells
embedded in collagen gel were treated with NaF combined with lactate under the normoxic or hypoxic conditions, and total RNAwas prepared 24 h later. Real-time RT-PCR analysis
was performed by using COL10a1 and b-actin-speciﬁc primers. The amount of expression of COL10a1 genes was normalized to the amount of b-actin. The graph shows the
expression of COL10a1 after the treatment with PBS (n ¼ 9) or NaF/lactate (n ¼ 6) under normoxia, and that after the treatment with PBS (n ¼ 7) or NaF/lactate (n ¼ 7) under
hypoxia. Bars represent mean values with 95% conﬁdence intervals. The ordinate indicates the relative ratio with respect to control sample under normoxia (ratio ¼ 1.0). Exact P-
values are shown between compared groups.
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articular cartilage, they vary in size and morphology, depending on
the zone of articular cartilage above the tidemark, which is divided
into three distinct ones, i.e., the superﬁcial, middle, and deep
zones31. Corresponding to these morphological differences, chon-
drocyte metabolism reportedly differs among these zones32. The
zonal difference in chondrocyte metabolism may be important in
the differential expression of hypertrophic chondrocyte-related
genes. In particular, it was reported that the expression level of
COL10a1 in the deep zone of OA cartilage is greater than that in
another zone32. In fact, we have preliminary data showing that
immunoreactivity of MCT2 was detectable in the deep zone of
normal articular cartilage (data not shown). Of note, chondrocytes
are recognized to produce a high level of lactate in the internal
zones of the avascular articular cartilage23. Under such conditions,
if metabolic activity in this deep zone of articular cartilage is
attenuated by aging or excess mechanical stress, chondrocytes mayundergo hypertrophy-like changes leading to the onset and pro-
gression of OA. Our preliminary immunohistochemical analysis
revealed that the immunoreactivity of GAPDH in the articular
cartilage of 18-month-old mice was less than that of the enzyme in
2-month-old mice (data not shown). In addition, we observed that
intracellular ATP production was decreased when excess mechan-
ical stress was loaded onto 3-D culture of HCS-2/8 cells (data not
shown). These ﬁndings indicate that metabolic activity is decreased
by aging or excess mechanical stress, which would induce
decreased glycolytic metabolic activity, thus accelerating hyper-
trophy of articular chondrocytes and leading to OA. In addition, it is
of particular interest and thus worth investigating whether similar
events may occur in the synovial tissue as well.
In conclusion, our study clariﬁed that decreased ATP production
in the presence of lactate plays an important role in alteration of
chondrocytes to the hypertrophy-like state. Further investigation is
needed to verify our hypothesis that the chondrocyte hypertrophy-
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Fig. 7. Western blot analysis of production of SOX9 and type X collagen, and activation of MMP9, in HCS-2/8 cells treated with NaF with or without lactate. (A) HCS-2/8 cells were
grown in DMEM containing 10% FBS until they had become conﬂuent. Then, the medium was replaced with serum-free DMEM, and the cells were subsequently treated with NaF
(2 mM), lactate (1 mM) or NaF combined with lactate. After 18 h, cell lysates were prepared; andWestern blotting was then performed by using anti-SOX9, anti-type X collagen, and
anti-b-actin antibodies. The amount of type X collagen and SOX9 was determined densitometrically and normalized to b-actin. Bars presented for type X collagen (n ¼ 3) and SOX9
(n ¼ 4) are mean values with 95% conﬁdence intervals. Exact P-values are shown between compared data sets. (B) After HCS-2/8 cells had reached conﬂuence, the medium was
replaced with serum-free medium containing NaF (2 mM), lactate (1 mM) or NaF combined with lactate. Conditioned media were collected 18 h later and concentrated with gelatin
Sepharose. Western blot analysis was performed by using anti-MMP9 antibody. The active form of MMP9 was detected in the medium conditioned by cells treated with NaF or NaF
combined with lactate but not when the cells had been treated with PBS (cont.) or lactate.
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